Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

Tofacitinib effectively treats Alopecia Areata.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Liquid nitrogen cryotherapy is an effective treatment for alopecia areata.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

The combination of laser and topical steroids is more effective for treating alopecia areata than topical steroids alone.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

People with alopecia areata have much lower Vitamin-D levels than healthy individuals.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.